Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Haematologica|March 26, 2026
Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemiaDaniel Nguyen, Elias Jabbour, Hagop M Kantarjian, et al.
Anaesthesia, Critical Care & Pain Medicine|March 22, 2026
Ventilator Weaning and Extubation in Acute Brain Injury: Challenges and Evidence-Based ApproachesLou'I Al-Husinat, Mohammad Araydah, Fadi Haddad, et al.
Journal of Blood Medicine|January 16, 2026
Risk Factors for Post-Operative Blood Transfusion and Association with Outcomes in Hip Fracture SurgeryLou'i Al-Husinat, Fadi Haddad, Sarah Al Sharie, et al.
Cancers|July 15, 2026
Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-AnalysisRita Ahmad, Motaz Almahmood, Rasha Kaddoura, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 27, 2026
Review of Bleeding as Initial Presentation in Patients with Chronic Myeloid LeukemiaMohammad ALTermanini, Omar Altrmanini, Abdulrhaman F Al-Mashdali, et al.
Cancer|May 29, 2024
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantationJayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, et al.
Blood Cancer Journal|September 30, 2021
Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangementsGhayas C Issa, Jabra Zarka, Koji Sasaki, et al.
Blood Advances|September 15, 2021
Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experienceGuillaume Richard-Carpentier, Hagop M Kantarjian, Guilin Tang, et al.
The British Journal of Ophthalmology|April 2, 2022
One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysisAlexander Tanner, Fadi Haddad, Julia Fajardo-Sanchez, et al.
Hemasphere|February 16, 2026
Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapiesJayastu Senapati, Jennifer Croden, Guillermo Garcia-Manero, et al.
Pageof 6